Antimicrobial prophylaxis in acute leukaemia: Prospective randomized study comparing two methods of selective decontamination

Klinische Wochenschrift

Volumn 61, Issue 14, 1983, Pages 691-698

  Kurrle, E ^a   Bhaduri, S ^a   Krieger, D ^a   Pflieger, H ^a   Heimpel, H ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Acute leukaemia; Infection prophylaxis; Selective decontamination

Indexed keywords

AMPHOTERICIN B; ASPARAGINASE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; FLUCYTOSINE; MERCAPTOPURINE; METHOTREXATE; NALIDIXIC ACID; NEOMYCIN; NYSTATIN; OXACILLIN; POLYMYXIN; PREDNISOLONE; TIOGUANINE; VINCRISTINE;

BLOOD AND HEMOPOIETIC SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM; DRUG THERAPY; ENTEROBACTERIACEAE; GASTROINTESTINAL TRACT; GRAM NEGATIVE INFECTION; HUMAN; INFECTION; LEUKEMIA; MOUTH; OROPHARYNX; PHARYNX; PREVENTION; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SEPSIS; THERAPY;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AMINOGLYCOSIDES; AMPHOTERICIN B; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CANDIDIASIS; CEPHALOSPORINS; ENTEROBACTERIACEAE INFECTIONS; FEMALE; FLUCYTOSINE; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; OXACILLIN; PENICILLINS; PROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS;

EID: 0020532506     PISSN: 00232173     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/BF01487614     Document Type: Article

References (29)

1. Causes of death in adults with acute leukemia
2. Bacteremia and fungemia complicating neoplastic disease
3. Bacterial infections and acute myeloblastic leukaemia: an analysis of two hundred patients undergoing intensive remission induction therapy
4. Origin of infection in acute nonlymphocytic leukemia
5. Fever and infection in leukemia patients
6. Protected environments and prophylactic antibiotics. — A prospective controlled study of their utility in the therapy of acute leukemia
7. A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients
8. Use of oral antibiotics in protected units environment: clinical effectiveness and role in the emergence of antibiotic-resistant strains
9. Infection prevention in acute nonlymphocytic leukemia: laminar air flow room reverse isolation with oral nonabsorbable antibiotic prophylaxis
10. Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. I. Clinical results
11. Evaluation of a protective environment in the management of granulocytopenic patients
12. Selective elimination of enterobacteriaceae species from the digestive tract in mice and monkeys
13. The colonization resistance of the digestive tract in experimental animals and its consequences for infection prevention, acquisition of new bacteria and prevention of spread of bacteria between cage mates
14. Partial antibiotic decontamination
15. Successful chemoprophylaxis for pneumocystis carinii pneumonits
16. A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients
17. Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract
18. Selective antimicrobial modulation of human microbial flora: infection prevention in patients with decreased host defense mechanisms by selective elimination of potentially pathogenic bacteria
19. A comparison of trimethoprimsulfamethoxazole plus nystain with gentamicin plus nystatin in the prevention of infections in acute leukemia
20. Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia
21. Co-trimoxazole alone for prevention of bacterial infection in patients with acute leukacmia
22. Co-trimoxazole versus non-absorbable antibiotics in acute leukaemia
23. Infection prophylaxis in acute leukaemia patients: comparison of selective and total antimicrobial decontamination of gastrointestinal tract
24. High remission induction rate in acute myeloid leukaemia
25. Multicentric therapy trial for acute lymphatic (ALL) and acute undifferentiated leukaemia (AUL) in adults
26. Design and analysis of randomized clinical trials requiring prolonged observation of each patients. II. Analysis and examples
27. Effect of trimethoprim or trimethoprim/sulfamethoxazole usage on the emergence of trimethoprim resistance in urinary tract pathogens
28. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim-sulfmethoxazole
29. Influence of total and selective decontamination on the aerobic and anaerobic gastrointestinal flora in patients with acute leukaemia